AEON Biopharma, Inc. (AEON)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20261 patent granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to AEON Biopharma, Inc.’s names, not what it holds today.
7 published
0 published
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Nov 28, 2023 | 11,826,405 | Neurotoxin compositions for use in treating headache | Pharmaceuticals | Aeon Biopharma, Inc. |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Aug 7, 2025 | 2025/0249081 | NEUROTOXIN COMPOSITIONS FOR USE IN MODULATING STELLATE GANGLION ACTIVITY | Pharmaceuticals | AEON Biopharma, Inc. |
| Feb 27, 2025 | 2025/0064906 | NEUROTOXIN COMPOSITIONS FOR USE IN TREATING DIGESTIVE DISORDERS | Pharmaceuticals | AEON Biopharma, Inc. |
| Feb 15, 2024 | 2024/0050540 | NEUROTOXIN COMPOSITIONS FOR USE IN TREATING HEADACHE | Pharmaceuticals | AEON Biopharma, Inc. |
| May 11, 2023 | 2023/0145940 | NEUROTOXIN COMPOSITIONS FOR USE IN TREATING CARDIOVASCULAR DISORDERS | Pharmaceuticals | AEON Biopharma, Inc. |
| Oct 20, 2022 | 2022/0331410 | NEUROTOXIN COMPOSITIONS FOR USE IN TREATING GASTROPARESIS | Pharmaceuticals | AEON Biopharma, Inc. |
| Sep 22, 2022 | 2022/0296687 | NEUROTOXIN COMPOSITIONS FOR USE IN TREATING NEUROLOGIC AND PSYCHIATRIC DISORDERS | Pharmaceuticals | AEON Biopharma, Inc. |
| Mar 4, 2021 | 2021/0060144 | NEUROTOXIN COMPOSITIONS FOR USE IN TREATING HEADACHE | Pharmaceuticals | AEON Biopharma, Inc. · patent 11,826,405 granted from it |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.